Dr Steven Mercer, the CEO said, “The decision to withdraw the request for Scientific Opinionfor CE Mark.
does not impact Tissue Therapies’ ongoing plans to obtain approval for VitroGro® ECM in the
USA. The procedure for US FDA approval for the use of VitroGro® ECM is different from that
Interesting that this is the comment he makes.....perhaps we may get approval in the US in the not so distant future.